Literature DB >> 26547631

Tonically active NMDA receptors--a signalling mechanism critical for interneuronal excitability in the CA1 stratum radiatum.

Ilse Riebe1, Henrik Seth1, Georgia Culley1, Zita Dósa2, Shayma Radi1, Karin Strand1, Victoria Fröjd1, Eric Hanse1.   

Abstract

In contrast to tonic extrasynaptic γ-aminobutyric acid (GABA)A receptor-mediated signalling, the physiological significance of tonic extrasynaptic N-methyl-D-aspartate (NMDA) receptor (NMDAR)-mediated signalling remains uncertain. In this study, reversible open-channel blockers of NMDARs, memantine and phencyclidine (PCP) were used as tools to examine tonic NMDAR-mediated signalling in rat hippocampal slices. Memantine in concentrations up to 10 μM had no effect on synaptically evoked NMDAR-mediated responses in pyramidal neurons or GABAergic interneurons. On the other hand, 10 μM memantine reduced tonic NMDAR-mediated currents in GABAergic interneurons by approximately 50%. These tonic NMDAR-mediated currents in interneurons contributed significantly to the excitability of the interneurons as 10 μM memantine reduced the disynaptic inhibitory postsynaptic current in pyramidal cells by about 50%. Moreover, 10 μM memantine, but also PCP in concentrations ≤ 1 μM, increased the magnitude of the population spike, likely because of disinhibition. The relatively higher impact of tonic NMDAR-mediated signalling in interneurons was at least partly explained by the expression of GluN2D-containing NMDARs, which was not observed in mature pyramidal cells. The current results are consistent with the idea that low doses of readily reversible NMDAR open-channel blockers preferentially inhibit tonically active extrasynaptic NMDARs, and they suggest that tonically active NMDARs contribute more prominently to the intrinsic excitation in GABAergic interneurons than in pyramidal cells. It is proposed that this specific difference between interneurons and pyramidal cells can explain the disinhibition caused by the Alzheimer's disease medication memantine.
© 2015 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; disinhibition; extrasynaptic; hippocampus; schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26547631     DOI: 10.1111/ejn.13128

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

Review 1.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

2.  Tonic Activation of GluN2C/GluN2D-Containing NMDA Receptors by Ambient Glutamate Facilitates Cortical Interneuron Maturation.

Authors:  Elizabeth Hanson; Moritz Armbruster; Lauren A Lau; Mary E Sommer; Zin-Juan Klaft; Sharon A Swanger; Stephen F Traynelis; Stephen J Moss; Farzad Noubary; Jayashree Chadchankar; Chris G Dulla
Journal:  J Neurosci       Date:  2019-03-07       Impact factor: 6.167

3.  The Emergence of a Stable Neuronal Ensemble from a Wider Pool of Activated Neurons in the Dorsal Medial Prefrontal Cortex during Appetitive Learning in Mice.

Authors:  Leonie S Brebner; Joseph J Ziminski; Gabriella Margetts-Smith; Meike C Sieburg; Hayley M Reeve; Thomas Nowotny; Johannes Hirrlinger; Tristan G Heintz; Leon Lagnado; Shigeki Kato; Kazuto Kobayashi; Leslie A Ramsey; Catherine N Hall; Hans S Crombag; Eisuke Koya
Journal:  J Neurosci       Date:  2019-11-14       Impact factor: 6.167

4.  Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.

Authors:  Nathan G Glasgow; Nadezhda V Povysheva; Andrea M Azofeifa; Jon W Johnson
Journal:  J Neurosci       Date:  2017-09-06       Impact factor: 6.167

Review 5.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

6.  NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.

Authors:  Zhihao Mao; Shengxi He; Christopher Mesnard; Paul Synowicki; Yuning Zhang; Lucy Chung; Alex I Wiesman; Tony W Wilson; Daniel T Monaghan
Journal:  Brain Res       Date:  2019-11-28       Impact factor: 3.252

7.  A Role for Prefrontal Cortical NMDA Receptors in Murine Alcohol-Heightened Aggression.

Authors:  Emily L Newman; Miho Terunuma; Tiffany L Wang; Nishani Hewage; Matthew B Bicakci; Stephen J Moss; Joseph F DeBold; Klaus A Miczek
Journal:  Neuropsychopharmacology       Date:  2017-10-20       Impact factor: 7.853

Review 8.  The origin of NMDA receptor hypofunction in schizophrenia.

Authors:  Kazu Nakazawa; Kiran Sapkota
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

Review 9.  Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.

Authors:  Lulu Yao; Qiang Zhou
Journal:  Neural Plast       Date:  2017-01-09       Impact factor: 3.599

10.  Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.

Authors:  Kazu Nakazawa; Vivek Jeevakumar; Kazuhito Nakao
Journal:  NPJ Schizophr       Date:  2017-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.